Your browser doesn't support javascript.
loading
Residual Disease after Neoadjuvant Therapy - Developing Drugs for High-Risk Early Breast Cancer.
Prowell, Tatiana M; Beaver, Julia A; Pazdur, Richard.
Afiliación
  • Prowell TM; From the Office of Hematology and Oncology Products, Center for Drug Evaluation and Research (T.M.P., J.A.B.), and the Oncology Center of Excellence (R.P.), Food and Drug Administration, Silver Spring, and the Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore (T.M.P., J.A.B.) - both in Maryland.
  • Beaver JA; From the Office of Hematology and Oncology Products, Center for Drug Evaluation and Research (T.M.P., J.A.B.), and the Oncology Center of Excellence (R.P.), Food and Drug Administration, Silver Spring, and the Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore (T.M.P., J.A.B.) - both in Maryland.
  • Pazdur R; From the Office of Hematology and Oncology Products, Center for Drug Evaluation and Research (T.M.P., J.A.B.), and the Oncology Center of Excellence (R.P.), Food and Drug Administration, Silver Spring, and the Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore (T.M.P., J.A.B.) - both in Maryland.
N Engl J Med ; 380(7): 612-615, 2019 Feb 14.
Article en En | MEDLINE | ID: mdl-30763188
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: N Engl J Med Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: N Engl J Med Año: 2019 Tipo del documento: Article